Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15494497rdf:typepubmed:Citationlld:pubmed
pubmed-article:15494497lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:15494497lifeskim:mentionsumls-concept:C0013081lld:lifeskim
pubmed-article:15494497lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:15494497lifeskim:mentionsumls-concept:C1555029lld:lifeskim
pubmed-article:15494497pubmed:issue9lld:pubmed
pubmed-article:15494497pubmed:dateCreated2004-10-20lld:pubmed
pubmed-article:15494497pubmed:abstractTextHIV Nef down-regulates CD4 from the cell surface in the absence of CD4 phosphorylation, whereas PMA down-regulates CD4 through a phosphorylation-dependent pathway. In this study we show that the down-regulation of CD4 in human Jurkat T cells expressing Nef was nearly complete (approximately 95%), whereas that induced by PMA was partial (approximately 40%). Unexpectedly, treating T cells expressing Nef with PMA restored the surface CD4 up to 35% of the steady state level. Both mutating the phosphorylation sites in the CD4 cytoplasmic tail (Ser408 and Ser415) and the use of a protein kinase C inhibitor, bisindolylmaleimide1, abolished the restoration of surface CD4, suggesting that the restoration required CD4 phosphorylation. CD4 and Nef could be cross-linked by a chemical cross-linker, 3,3-dithiobis[sulfosuccinimidyl-propionate], in control T cell membranes, but not in PMA-treated T cell membrane, suggesting that CD4 and Nef interacted with each other in T cells, and the phosphorylation disrupted the CD4-Nef interaction. We propose that this dissociation switches CD4 internalization from the Nef-mediated, nearly complete down-regulation to a phosphorylation-dependent, partial down-regulation, resulting in a net gain of CD4 on the T cell surface.lld:pubmed
pubmed-article:15494497pubmed:languageenglld:pubmed
pubmed-article:15494497pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15494497pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15494497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15494497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15494497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15494497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15494497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15494497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15494497pubmed:statusMEDLINElld:pubmed
pubmed-article:15494497pubmed:monthNovlld:pubmed
pubmed-article:15494497pubmed:issn0022-1767lld:pubmed
pubmed-article:15494497pubmed:authorpubmed-author:ZhangXiaoping...lld:pubmed
pubmed-article:15494497pubmed:authorpubmed-author:BurakoffSteve...lld:pubmed
pubmed-article:15494497pubmed:authorpubmed-author:JinYong-JiuYJlld:pubmed
pubmed-article:15494497pubmed:authorpubmed-author:BoursiquotJ...lld:pubmed
pubmed-article:15494497pubmed:issnTypePrintlld:pubmed
pubmed-article:15494497pubmed:day1lld:pubmed
pubmed-article:15494497pubmed:volume173lld:pubmed
pubmed-article:15494497pubmed:ownerNLMlld:pubmed
pubmed-article:15494497pubmed:authorsCompleteYlld:pubmed
pubmed-article:15494497pubmed:pagination5495-500lld:pubmed
pubmed-article:15494497pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:meshHeadingpubmed-meshheading:15494497...lld:pubmed
pubmed-article:15494497pubmed:year2004lld:pubmed
pubmed-article:15494497pubmed:articleTitleCD4 phosphorylation partially reverses Nef down-regulation of CD4.lld:pubmed
pubmed-article:15494497pubmed:affiliationSkirball Institute of Biomedical Research, New York University School of Medicine, New York, NY 10016, USA. jiny@saturn.med.nyu.edulld:pubmed
pubmed-article:15494497pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15494497pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15494497pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:920entrezgene:pubmedpubmed-article:15494497lld:entrezgene
entrez-gene:156110entrezgene:pubmedpubmed-article:15494497lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15494497lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15494497lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15494497lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15494497lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15494497lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15494497lld:pubmed